FDA transparency rebuffed in report

Share this article:
A minority staff report from the House Energy & Commerce Committee says FDA deputy commissioner Janet Woodcock and her successor as director of drugs Steven Galson had the lowest reporting rates of all agency officials required to report their meetings with industry and outside entities.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions